Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Radiolabeling efficiency of FENTA chelators and stability of their terbium-161, lutetium-177 and bismuth-213 complexes
Bonneux, C., Rodríguez Pérez, S., Heinitz, S., Bogaerts, V., Van de Voorde, M., Cardinaels, T., Ooms, M., Dehaen, W. & Opsomer, T., Dec 2026, In: EJNMMI Radiopharmacy and Chemistry. 11, 1, 24 p., 36.Research output › peer-review
Open Access -
Synthesis and evaluation of HOPO-O8-Methyl-tetrazine as a bifunctional chelator for use in [89Zr]Zr4+, [161Tb]Tb3+ and [227Th]Th4+ radioimmunoconjugates
Carbo-Bague, I., Randhawa, K., Tosato, M., McNeil, B. L., Colovic, M., London, L., Rodriguez-Rodriguez, C., Osooly, M., Wharton, L., Merkens, H., Van de Voorde, M., Ooms, M., Yang, H., Bénard, F. & Ramogida, C. F., Jan 2026, In: Journal of Inorganic Biochemistry. 274, 13 p., 113077.Research output › peer-review
Open AccessFile70 Downloads (Pure) -
Comparison of the Treatment Efficacy of 161Tb- and 177Lu-Labeled GRPR Antagonists in PC3 Tumor-Bearing Mice
Günther, T., Moses, A., Gunter, E., Landry, M., Ramaekers, S., Van de Voorde, M., Ooms, M., Ponsard, B. & Beinat, C., 2025, In: Journal of Nuclear Medicine. 66, Supplement 1, 1 p., 251613.Research output › peer-review
Open Access -
Cysteine-selective [188Re]Re(v) radiolabelling of a Nanobody® for targeted radionuclide therapy using a “chelate-then-click” approach
Melis, D. R., Segers, C., Wellens, J., Van de Voorde, M., Blacque, O., Ooms, M., Gasser, G. & Opsomer, T., 26 Feb 2025, In: Chemical Science. p. 10Research output › peer-review
Open Access -
Mitochondria-tropic radioconjugates to enhance the therapeutic potential of terbium-161
Santos, J. F., Laere, C. V., Silva, C. D., Cassells, I., Fernandes, C., Raposinho, P., Belchior, A., Pinto, C. I. G., Mendes, F., Cawthorne, C., Ooms, M., Voorde, M. V. D., Cleeren, F. & Paulo, A., Dec 2025, In: EJNMMI Radiopharmacy and Chemistry. 10, 1, 15 p., 18.Research output › peer-review
Open Access